Clinical Trial Update: A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer [NA]

View source ↗

Summary

This clinical trial outlines a screening program to improve early detection of pancreatic cancer in individuals at high risk and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Mayo Clinic | Conditions: Pancreatic Ductal Adenocarcinoma | NA | Status: RECRUITING